<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="correction" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1123234</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2022.1123234</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Erratum</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Erratum: Advances in RIPK1 kinase inhibitors</article-title>
<alt-title alt-title-type="left-running-head">Frontiers Production Office</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2022.1123234">10.3389/fphar.2022.1123234</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<collab>Frontiers Production Office</collab>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<uri xlink:href="https://loop.frontiersin.org/people/20170/overview"/>
</contrib-group>
<aff>
<institution>Frontiers Media SA</institution>, <addr-line>Lausanne</addr-line>, <country>Switzerland</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Approved by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/20178">Frontiers Editorial Office</ext-link>, Frontiers Media SA, Switzerland</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Frontiers Production Office, <email>production.office@frontiersin.org</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>01</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>1123234</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>12</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>12</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Frontiers Production Office.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Frontiers Production Office</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front Endocrinol (Lausanne)" journal-id-type="nlm-ta" xlink:href="10.3389/fphar.2022.976435" ext-link-type="doi">An Erratum on <article-title>Advances in RIPK1 kinase inhibitors</article-title> by Chen L, Zhang X, Ou Y, Liu M, Yu D, Song Z, Niu L, Zhang L and Shi J (2022). Front. Pharmacol. 13:976435. doi: <object-id>10.3389/fphar.2022.976435</object-id>
</related-article>
<kwd-group>
<kwd>inhibitor</kwd>
<kwd>receptor interacting protein 1 (RIP1)</kwd>
<kwd>programmed necrosis</kwd>
<kwd>necrosis</kwd>
<kwd>RIP1 (RIPK1)</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Due to a production error, the list of affiliations used for the authors was incorrect. The correct affiliations list is shown below.</p>
<p>Lu Chen<sup>1,2,&#x2020;</sup>, Xiaoqin Zhang<sup>3,&#x2020;</sup>, Yaqing Ou<sup>4,&#x2020;</sup>, Maoyu Liu<sup>1,2,&#x2020;</sup>, Dongke Yu<sup>1,2</sup>, Zhiheng Song<sup>5</sup>, Lihong Niu<sup>6,</sup>&#x2a;, Lijuan Zhang<sup>1,2,</sup>&#x2a; and Jianyou Shi<sup>1,2,</sup>&#x2a;</p>
<p>
<sup>1</sup>Department of Pharmacy, Sichuan Academy of Medical Sciences &#x26; Sichuan Provincial People&#x2019;s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China</p>
<p>
<sup>2</sup>Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China</p>
<p>
<sup>3</sup>Department of Critical Care Medicine, Sichuan Academy of Medical Sciences &#x26; Sichuan Provincial People&#x2019;s Hospital, Affiliated Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan, China</p>
<p>
<sup>4</sup>Department of Pharmacy, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, Sichuan, China</p>
<p>
<sup>5</sup>Suzhou University of Science and Technology, Suzhou, Jiangsu, China, 6 Institute of Laboratory Animal Sciences, Academy of Medical Sciences and Sichuan Provincial People&#x2019;s Hospital, Chengdu, Sichuan, China</p>
<p>The publisher apologizes for this mistake. The original version of this article has been updated.</p>
</body>
</article>